Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT01010750 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit Hyperactivity Disorder

Interventions

DRUG: Lisdexamfetamine Dimesylate (LDX)
DRUG: Immediate Release Mixed Amphetamine Salts (MAS-IR)
DRUG: LDX Placebo + MAS-IR Placebo

Sponsor

Shire